Literature DB >> 16168689

Exploring protein-ligand recognition with Binding MOAD.

Richard D Smith1, Liegi Hu, Jayson A Falkner, Mark L Benson, Jason P Nerothin, Heather A Carlson.   

Abstract

We have recently announced the largest database of protein-ligand complexes, Binding MOAD (Mother of All Databases). After the August 2004 update, Binding MOAD contains 6816 complexes. There are 2220 protein families and 3316 unique ligands. After searching 6000+ crystallography papers, we have obtained binding data for 1793 (27%) of the complexes. We have also created a non-redundant set of complexes with only one complex from each protein family; in that set, 630 (28%) of the unique complexes have binding data. Here, we present information about the data provided at the Binding MOAD website. We also present the results of mining Binding MOAD to map the degree of solvent exposure for binding sites. We have determined that most cavities and ligands (70-85%) are well buried in the complexes. This fits with the common paradigm that a large degree of contact between the ligand and protein is significant in molecular recognition. GoCAV and the GoCAV viewer are the tools we created for this study. To share our data and make our online dataset more useful to other research groups, we have integrated the viewer into the Binding MOAD website (www.BindingMOAD.org).

Mesh:

Substances:

Year:  2005        PMID: 16168689     DOI: 10.1016/j.jmgm.2005.08.002

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  18 in total

Review 1.  A cheminformatic toolkit for mining biomedical knowledge.

Authors:  Gus R Rosania; Gordon Crippen; Peter Woolf; David States; Kerby Shedden
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 2.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

3.  Lessons for fragment library design: analysis of output from multiple screening campaigns.

Authors:  I-Jen Chen; Roderick E Hubbard
Journal:  J Comput Aided Mol Des       Date:  2009-06-03       Impact factor: 3.686

4.  Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction.

Authors:  Yun Song; Emilio Margolles-Clark; Allison Bayer; Peter Buchwald
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

5.  Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.

Authors:  Idira Obasse; Mark Taylor; Nigel J Fullwood; David Allsop
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

Review 6.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

7.  Biophysical limits of protein-ligand binding.

Authors:  Richard D Smith; Alaina L Engdahl; James B Dunbar; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2012-07-18       Impact factor: 4.956

8.  Differences between high- and low-affinity complexes of enzymes and nonenzymes.

Authors:  Heather A Carlson; Richard D Smith; Nickolay A Khazanov; Paul D Kirchhoff; James B Dunbar; Mark L Benson
Journal:  J Med Chem       Date:  2008-10-01       Impact factor: 7.446

9.  Structural properties of non-traditional drug targets present new challenges for virtual screening.

Authors:  Ragul Gowthaman; Eric J Deeds; John Karanicolas
Journal:  J Chem Inf Model       Date:  2013-08-13       Impact factor: 4.956

10.  Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity.

Authors:  Tong Zhang; Weixin Xu; Yuguang Mu; Philippe Derreumaux
Journal:  ACS Chem Neurosci       Date:  2013-11-22       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.